z-logo
open-access-imgOpen Access
The PRKD1 promoter is a target of the KRas-NF-κB pathway in pancreatic cancer
Author(s) -
Heike Döppler,
Richard Panayiotou,
Elizabeth M. Reid,
Willibroad Maimo,
Ligia I. Bastea,
Peter Störz
Publication year - 2016
Publication title -
scientific reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.24
H-Index - 213
ISSN - 2045-2322
DOI - 10.1038/srep33758
Subject(s) - kras , cancer research , pancreatic cancer , gene , mechanism (biology) , signal transduction , nf κb , biology , gene expression , cancer , mutation , genetics , philosophy , epistemology
Increased expression of PRKD1 and its gene product protein kinase D1 (PKD1) are linked to oncogenic signaling in pancreatic ductal adenocarcinoma, but a direct functional relationship to oncogenic KRas has not been established so far. We here describe the PRKD1 gene promoter as a target for oncogenic KRas signaling. We demonstrate that KRas-induced activation of the canonical NF-κB pathway is one mechanism of how PRKD1 expression is increased and identify the binding sites for NF-κB in the PRKD1 promoter. Altogether, these results describe a novel mechanism governing PRKD1 gene expression in PDA and provide a functional link between oncogenic KRas, NF-κB and expression of PRKD1 .

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom